Drug Type Chemical drugs, Diagnostic radiopharmaceuticals |
Synonyms N-(4-Methoxy-13C-phenyl)acetamide, 碳[13C]美沙西汀 |
Target- |
Action enhancers |
Mechanism PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chemical and Drug Induced Liver Injury | Phase 3 | United States | 10 Jun 2016 | |
Chemical and Drug Induced Liver Injury | Phase 3 | United States | 10 Jun 2016 | |
Liver Failure, Acute | Phase 3 | United States | 10 Jun 2016 | |
Liver Failure, Acute | Phase 3 | United States | 10 Jun 2016 | |
liver function failure | Phase 3 | Germany | 31 Jan 2013 | |
Pulmonary Disease, Chronic Obstructive | Phase 3 | Israel | 30 Sep 2010 | |
Hepatitis B, Chronic | Phase 3 | Israel | 17 Sep 2010 | |
Chronic liver disease | Phase 3 | United States | 01 Sep 2005 | |
Fibrosis | Phase 3 | United States | 01 Sep 2005 | |
Nonalcoholic Steatohepatitis | Phase 3 | United States | 01 Sep 2005 |
Not Applicable | - | - | 13C-Methacetin Breath Tyttrium-90 (Radioembolization with yttrium-90-loaded resin microspheres) | fcdrwsbelu(zyjwviqgrq) = significant increase after 7 days ocsfcujrhu (hinjtpjuqz ) View more | - | 28 Aug 2023 | |
Not Applicable | 124 | cuwjvcprcr(vkqedfuiny) = cdtjwdkbgw kszofmcvhj (mqyctjhmtr, 31.58) View more | - | 09 Aug 2022 | |||
Phase 2/3 | 76 | eijdeyzodu(dicjckhzef) = frzoxkmacm phxgqbfdke (gezdzbgdfb, 7.8) View more | - | 22 Dec 2020 | |||
Not Applicable | 15 | (TIPS placement) | mggmdywmwq(yaxveaqbeg) = louuffuzdh zdgtnluqfo (rztjcgcofy, 753 - 61) | - | 27 Aug 2020 |